Top Quality Consultancy within Data Science

Biostatistics, Statistical Programming and Real-world Evidence.

Team

Our Team

Image

Søren Lophaven

Director, Senior Statistician

Søren holds a Msc in Engineering from the Technical University of Denmark and a PhD in Statistics. He has worked as a statistician within research and in the life science industry for more than 15 years. He founded Omicron in August 2019.

Image

Klaus Kaae Andersen

Director, Senior Statistician

Klaus holds a PhD in Statistics. He has been Associate Professor in Statistics at the Technical University of Denmark and Head of Statistics and Epidemiology at the Danish Cancer Society for a number of years. Most recently he worked as Real World Evidence expert at Astra Zeneca.

Image

Konstantinos Lymperis

Senior Statistical Programmer

Konstantinos holds a Msc in Engineering from the Technical University of Denmark. He has worked as a statistical programmer in a CRO for 3½ years and joined Omicron in May 2021. Konstantinos has worked within several disease areas such as diabetes, CNS and dermatology.

Image

Thomas Boukouvalas

Statistical Programmer

Thomas holds a Msc in Business Administration & Innovation in Health Care from Copenhagen Business School. His Master Thesis was about barriers and facilitators for the implementation of electronic medical records. He joined Omicron in September 2021.







Image

Gertrud Dam-Dalgeir

Senior Data Scientist

Gertrud holds a Msc in Physics from the Niels Bohr Institute, University of Copenhagen. She has worked as a statistical programmer in the pharmaceutical industry for 3 years and has been teaching physics at high school level. Gertrud joined Omicron in November 2021.

Career

Working with us

Services

Services

Biostatistics

All aspects of biostatistics, e.g. statistical analysis of clinical trial and real-world data, meta- and network meta-analyses, working on a Data Monitoring Committee (DMC).

Statistical Programming

Statistical programming in SAS and R for creating CDISC datasets, dataset documentation, output of study results and advanced graphics. Omicron is a gold member of the CDISC organization.

Real-world Evidence

We have extensive experience in epidemiology, analysis of Electronic Medical Record (EMR) clinical data from commercial databases and analysis of register data from Danish health registers.

Scientific communication

We have more than 180 publications in peer-reviewed scientific journals, and can help you producing your next abstract, poster, manuscript for a journal etc.

Outsourcing

We offer ourselves as a temporary resource in biostatistics, programming and real world evidence to your organization, so that you can move with speed. We understand the importance of close collaboration and adapting to client’s ways of working.

Interactive dashboards

Dashboards are useful to get fast insights into the most important aspects of your data. We host our own secure server solution and offer to build tailor-made interactive dashboards and reports (R Shiny apps and R Markdown) which allows you to explore your data in a dynamic way.

Training

Our team has long experience in arranging and providing training both in universities and private companies. We offer training within statistics, epidemiology and in using real world evidence for reimbursement and scientific engagement. The training is tailor-made, and customers own real world studies can be used as a starting point. We aim at making our teaching as interactive and fun.

Publications

Recent publications

Insights into the early use of oral semaglutide in routine clinical practice: The IGNITE study. 2021.


In: Diabetes, Obesity and Metabolism

Learn More

Outcomes in GLP-1 RA-experienced patients switching to once-weekly semaglutide in a real-world setting: The retrospective, observational EXPERT study. 2021.
In: Diabetes Therapy

Learn More

We have more than 180 publications in peer-reviewed scientific journals. A full list of publications can be provided on request

Projects

Current projects

clinicaltrials.gov

Searching clinicaltrials.gov is easy, but getting an overview of your search results can be complicated. We are developing software that can help giving this overview. For example, our recent app shows which clinical sites are being used in clinical trials within depression, psoriasis and atopic dermatitis. Check it out here.

Reporting clinical trials

We are building an IT setup as well as standard procedures and programs in R and SAS for working with clinical trial data in a validated way.

DACE - a Matlab kriging toolbox

Parts of DACE is being used by e-GEOS and by Lamassu Petroleum Solutions Pty. Ltd from Australia. Learn More about DACE.



Recent

News

Søren LophavenJanuary, 2022

Klaus Kaae Andersen joins Omicron as Director, Senior Statistician

Søren Lophaven November, 2021

I am giving a presentation about data management and statistics in clinical trials at atrium

Søren Lophaven November, 2021

We are attending the R/Pharma 2021 Conference. Learn More

Søren Lophaven November, 2021

Gertrud Dam-Dalgeir joins Omicron as Senior Data Scientist

Søren Lophaven October, 2021

Our manuscript entitled "Surgery, cancer and mortality among patients with ulcerative colitis diagnosed 1962-1987 and followed until 2017 in a Danish population-based inception cohort" was published in Alimentary Pharmacology and Therapeutics. Learn More

Søren Lophaven September, 2021

Our manuscript entitled "The clinical course of Crohn's disease in a Danish population-based inception cohort with more than 50 years of follow-up, 1962-2017" was published in Alimentary Pharmacology and Therapeutics. Learn More

Søren Lophaven September, 2021

Thomas Boukouvalas joins Omicron as Statistical Programmer

Søren Lophaven July, 2021

Our manuscript entitled "Microscopic colitis in Denmark: regional variations in risk factors and frequency of endoscopic procedures" was published in Journal of Crohns and Colitis. Learn More

Søren Lophaven June, 2021

Our manuscript entitled "Cancer incidence in Thyborøn-Harboøre, Denmark: a cohort study from an industrially contaminated site" was published in Scientific Reports. Learn More

Søren Lophaven June, 2021

We are attending the 2021 PSI Online Conference. Learn More

Søren Lophaven June, 2021

Our manuscript entitled "Insights into the early use of oral semaglutide in routine clinical practice: The IGNITE study" was published in Diabetes, Obesity and Metabolism. Learn More

Søren Lophaven May, 2021

Konstantinos Lymperis joins Omicron as Senior Statistical Programmer

Søren Lophaven April, 2021

Our manuscript entitled "Does Lolland-Falster make people sick, or do sick people move to Lolland-Falster? An example of selective migration and mortality in Denmark, 1968-2017" was published in Social Science & Medicine. Learn More

Søren Lophaven March, 2021

Simon Kruse and Villads Stokbro joins Omicron as Assistant Data Scientists

Søren Lophaven February, 2021

Our manuscript entitled "Outcomes in GLP-1 RA-experienced patients switching to once-weekly semaglutide in a real-world setting: The retrospective, observational EXPERT study" was published in Diabetes Therapy. Learn More

Søren Lophaven November, 2020

I am giving a presentation about data management and statistics in clinical trials at atrium

Søren Lophaven October, 2020

Our manuscript entitled "Disease activity patterns, mortality and colorectal cancer risk in microscopic colitis: a Danish nationwide cohort study, 2001 to 2016" was published in Journal of Crohns and Colitis. Learn More

Søren Lophaven June, 2020

Our manuscript entitled "Incidence and prevalence of microscopic colitis between 2001 and 2016: A Danish nationwide cohort study" was published in Journal of Crohns and Colitis. Learn More

Søren Lophaven April, 2020

Our manuscript entitled "High incidence of dementia in Faroese-born female residents in Denmark" was published in Alzheimer's & Dementia: Translational Research & Clinical Interventions. Learn More

Søren Lophaven Feb 28-29, 2020

I am attending the celebRation workshop to mark the 20th anniversary of the release of R version 1.0.0.

Søren Lophaven Oct 31, 2019

I am attending the annual meeting of the Danish Society for Pharmacoepidemiology: The clinical implications of pharmacoepidemiological research